Read + Share
Amedeo Smart
Independent Medical Education
Molinelli E, Simonetti O. Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa. Lancet 2024;403:2457-2459.PMID: 38797173
Email
LinkedIn
Facebook
Twitter
Privacy Policy